153 related articles for article (PubMed ID: 12691710)
1. Indirect human exposure to pharmaceuticals via drinking water.
Webb S; Ternes T; Gibert M; Olejniczak K
Toxicol Lett; 2003 May; 142(3):157-67. PubMed ID: 12691710
[TBL] [Abstract][Full Text] [Related]
2. Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data.
Houtman CJ; Kroesbergen J; Lekkerkerker-Teunissen K; van der Hoek JP
Sci Total Environ; 2014 Oct; 496():54-62. PubMed ID: 25058934
[TBL] [Abstract][Full Text] [Related]
3. Human pharmaceuticals in US surface waters: a human health risk assessment.
Schwab BW; Hayes EP; Fiori JM; Mastrocco FJ; Roden NM; Cragin D; Meyerhoff RD; D'Aco VJ; Anderson PD
Regul Toxicol Pharmacol; 2005 Aug; 42(3):296-312. PubMed ID: 15979221
[TBL] [Abstract][Full Text] [Related]
4. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
Cunningham VL; Binks SP; Olson MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):39-45. PubMed ID: 19013494
[TBL] [Abstract][Full Text] [Related]
5. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
Willhite CC; Ball GL; McLellan CJ
Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
[TBL] [Abstract][Full Text] [Related]
6. Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption.
Vulliet E; Cren-Olivé C
Environ Pollut; 2011 Oct; 159(10):2929-34. PubMed ID: 21570166
[TBL] [Abstract][Full Text] [Related]
7. Historical reconstruction of wastewater and land use impacts to groundwater used for public drinking water: exposure assessment using chemical data and GIS.
Swartz CH; Rudel RA; Kachajian JR; Brody JG
J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):403-16. PubMed ID: 12973368
[TBL] [Abstract][Full Text] [Related]
8. Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water.
de Jongh CM; Kooij PJ; de Voogt P; ter Laak TL
Sci Total Environ; 2012 Jun; 427-428():70-7. PubMed ID: 22551934
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health.
Simazaki D; Kubota R; Suzuki T; Akiba M; Nishimura T; Kunikane S
Water Res; 2015 Jun; 76():187-200. PubMed ID: 25835589
[TBL] [Abstract][Full Text] [Related]
10. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
[TBL] [Abstract][Full Text] [Related]
11. Occurrence and human health risk of wastewater-derived pharmaceuticals in a drinking water source for Shanghai, East China.
Wen ZH; Chen L; Meng XZ; Duan YP; Zhang ZS; Zeng EY
Sci Total Environ; 2014 Aug; 490():987-93. PubMed ID: 24914528
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceuticals, perfluorosurfactants, and other organic wastewater compounds in public drinking water wells in a shallow sand and gravel aquifer.
Schaider LA; Rudel RA; Ackerman JM; Dunagan SC; Brody JG
Sci Total Environ; 2014 Jan; 468-469():384-93. PubMed ID: 24055660
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water.
Kümmerer K; Al-Ahmad A
Environ Sci Pollut Res Int; 2010 Feb; 17(2):486-96. PubMed ID: 19548016
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of so called organic trace compounds in drinking water from the regulatory, health and aesthetic-quality points of view, with special consideration given to pharmaceuticals].
Dieter HH; Mückter H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Mar; 50(3):322-31. PubMed ID: 17334888
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of pharmaceuticals in a water supply system and related human health risk assessment.
de Jesus Gaffney V; Almeida CM; Rodrigues A; Ferreira E; Benoliel MJ; Cardoso VV
Water Res; 2015 Apr; 72():199-208. PubMed ID: 25453834
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California.
Fram MS; Belitz K
Sci Total Environ; 2011 Aug; 409(18):3409-17. PubMed ID: 21684580
[TBL] [Abstract][Full Text] [Related]
17. Health and ecological risk assessment of emerging contaminants (pharmaceuticals, personal care products, and artificial sweeteners) in surface and groundwater (drinking water) in the Ganges River Basin, India.
Sharma BM; Bečanová J; Scheringer M; Sharma A; Bharat GK; Whitehead PG; Klánová J; Nizzetto L
Sci Total Environ; 2019 Jan; 646():1459-1467. PubMed ID: 30235631
[TBL] [Abstract][Full Text] [Related]
18. Drugs, diagnostic agents and disinfectants in wastewater and water--a review.
Kümmerer K
Schriftenr Ver Wasser Boden Lufthyg; 2000; 105():59-71. PubMed ID: 10842795
[TBL] [Abstract][Full Text] [Related]
19. [Measures for minimizing the introduction of human pharmaceuticals and their residues into untreated water used to prepare drinking water : recommendation from the German Federal Environment Agency from 30 August 2011 after the hearing of the Drinking Water Commission of the German Federal Ministry of Health].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Jan; 55(1):143-9. PubMed ID: 22286260
[No Abstract] [Full Text] [Related]
20. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water.
Mompelat S; Le Bot B; Thomas O
Environ Int; 2009 Jul; 35(5):803-14. PubMed ID: 19101037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
